Treating COVID-19 with Qingfei Paidu Decoction with and without Ephedra Herba: A Retrospective Case Series
暂无分享,去创建一个
Sang-kwan Lee | Kwang-ho Kim | Cheol-hyun Kim | Young-ung Lee | Sunny Kang | G. Kang | S. Ji | Juhwan Song
[1] Tingting Guo,et al. The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin. , 2021, Journal of ethnopharmacology.
[2] Dong-Uk Park,et al. Recommendation for the establishment of a poison control center at the Korea Disease Control and Prevention Agency , 2020, Environmental analysis, health and toxicology.
[3] H. Chu,et al. Telemedicine Center of Korean Medicine for treating patients with COVID-19: a retrospective analysis , 2020, Integrative Medicine Research.
[4] Choi, You-kyung,et al. The Effects of Qingfei Paidu Decoction on Coronavirus Disease-19: A Narrative Review , 2020 .
[5] Dongsu Kim,et al. Telemedicine and the Use of Korean Medicine for Patients With COVID-19 in South Korea: Observational Study , 2020, JMIR public health and surveillance.
[6] Xinxin Zhang,et al. Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China , 2020, Cell Discovery.
[7] Tzou-Yien Lin,et al. Mechanism by which ma-xing-shi-gan-tang inhibits the entry of influenza virus. , 2012, Journal of ethnopharmacology.
[8] Ju-Il Lee,et al. The Effects of Saganmahwang-tang and prescription C on airway mucin secretion , 2006 .